Ir directamente a la navegación principal Ir directamente a la búsqueda Ir directamente al contenido principal

Improvement of Oral Bioavailability of Pyrazolo-Pyridone Inhibitors of the Interaction of DCN1/2 and UBE2M

  • Ho Shin Kim
  • , Jared T. Hammill
  • , Daniel C. Scott
  • , Yizhe Chen
  • , Amy L. Rice
  • , William Pistel
  • , Bhuvanesh Singh
  • , Brenda A. Schulman
  • , R. Kiplin Guy

Producción científica: Article › revisión exhaustiva

22 Citas (Scopus)

Resumen

The cullin-RING ubiquitin ligases (CRLs) are ubiquitin E3 enzymes that play a key role in controlling proteasomal degradation and are activated by neddylation. We previously reported inhibitors that target CRL activation by disrupting the interaction of defective in cullin neddylation 1 (DCN1), a CRL neddylation co-E3, and UBE2M, a neddylation E2. Our first-generation inhibitors possessed poor oral bioavailability and fairly rapid clearance that hindered the study of acute inhibition of DCN-controlled CRL activity in vivo. Herein, we report studies to improve the pharmacokinetic performance of the pyrazolo-pyridone inhibitors. The current best inhibitor, 40, inhibits the interaction of DCN1 and UBE2M, blocks NEDD8 transfer in biochemical assays, thermally stabilizes cellular DCN1, and inhibits anchorage-independent growth in a DCN1 amplified squamous cell carcinoma cell line. Additionally, we demonstrate that a single oral 50 mg/kg dose sustains plasma exposures above the biochemical IC90 for 24 h in mice.

Idioma originalEnglish
Páginas (desde-hasta)5850-5862
Número de páginas13
PublicaciónJournal of Medicinal Chemistry
Volumen64
N.º9
DOI
EstadoPublished - may 13 2021

Nota bibliográfica

Publisher Copyright:
© 2021 American Chemical Society. All rights reserved.

Financiación

FinanciadoresNúmero del financiador
National Institute of General Medical Sciences DP2GM119177 Sophie Dumont National Institute of General Medical SciencesF32GM113310
National Institute of General Medical Sciences DP2GM119177 Sophie Dumont National Institute of General Medical Sciences

    ASJC Scopus subject areas

    • Molecular Medicine
    • Drug Discovery

    Huella

    Profundice en los temas de investigación de 'Improvement of Oral Bioavailability of Pyrazolo-Pyridone Inhibitors of the Interaction of DCN1/2 and UBE2M'. En conjunto forman una huella única.

    Citar esto